SachinBhatmuley

Associate

San Diego + 1.858.314.1129

Connect:

Share

Sachin Bhatmuley represents clients in technology licensing and other complex technology-related transactions. Sachin helps clients achieve their business objectives by structuring and negotiating transactions in a broad range of technologies.

Sachin has extensive experience working with licensees and early-state device makers in the 4G/5G wireless communications space. He also has experience litigating complex patent disputes before district courts and the Patent Trial and Appeal Board (PTAB). Sachin has represented clients in software, semiconductors, mobile payments, wireless communications, and 3D-bioprinting litigations.

Prior to his law practice, Sachin was a technology licensing executive at a large technology company, where he established the company's sub-Sahara Africa presence. He also architected, established, and ran the company's Design in India Challenge and its in-house technology incubator. The success of this program led to the program being replicated in the company's other regional offices across Asia. Sachin has worked in multiple countries and has traveled extensively within Africa, Southeast Asia, and Europe.

Sachin also maintains an active pro bono practice representing clients in domestic violence restraining orders (DVROs), guardianship, and immigration matters.

Sachin coaches trial techniques and legal principles to high school students as an attorney coach for the San Diego High School Mock Trial Competition.

Experience

  • STERIS sells dental segment to an affiliate of Peak Rock CapitalJones Day is advising STERIS Plc in the $787.5 million sale of Dental segment to Peak Rock Capital, a leading middle-market private investment firm.
  • Direct lender provides $87 million senior secured credit facility to large private equity-backed provider of medical supplies to companies in commercial cruise and shipping industriesJones Day advised a direct lender, as administrative agent, collateral agent, sole lead arranger, and lender, in connection with a $87 million senior secured credit facility provided to a large private equity sponsored company that provides medical supplies to companies in the commercial cruise and shipping industries.
  • J.F. Lehman & Company acquires Mission MicrowaveJones Day advised J.F. Lehman & Company in the acquisition and financing of all of the outstanding membership interests of Mission Microwave Technologies, LLC, a revolutionary designer of radio frequency and microwave electronics supporting ground-based, airborne and space-based applications.
  • Newell Brands amends $1 billion revolving credit facilityJones Day represented Newell Brands Inc. (“Newell”), a leading consumer products company, in connection with the amendment restructuring its existing revolving credit facility.
  • EagleTree Capital acquires Summit Hill FoodsJones Day advised EagleTree Capital in the acquisition and financing of Summit Hill Foods, Inc., a leading branded food company producing nationally recognized, premium brands, including Better Than Bouillon and The Original Louisiana Hot Sauce.
  • J.F. Lehman & Company portfolio company acquires White Lake Dock & DredgeJones Day advised J.F. Lehman & Company in the acquisition and financing by portfolio company, ENTACT, LLC, of White Lake Dock & Dredge, Inc.
  • Cibus combines with CalyxtJones Day advised Cibus Global, LLC (“Cibus”), a San Diego based leader in precision gene editing in agriculture, in connection with an all-stock merger with Calyxt, Inc. (NASDAQ: CLXT), under which Cibus and Calyxt created an industry-leading company that combines two pioneers in agriculture-based gene editing and establishes one of the world’s most sophisticated facilities for trait development and plant breeding.
  • Genomatica grants license to make bio-based, sustainable BDO to Hyosung TNC for manufacture of bio-based SpandexJones Day represented Genomatica, Inc. in its license to Hyosung TNC under Genomatica's proprietary, bio-based process and engineered microorganisms to manufacture 1,4 butanediol (BDO) by fermentation of sugar sources.
  • Junshi grants exclusive rights to Dr. Reddy's for toripalimab cancer treatmentJones Day represented Shanghai Junshi Biosciences Co., Ltd. ("Junshi") in its grant of exclusive rights related to the development and commercialization of toripalimab, an anti-PD1 monoclonal antibody, to Dr. Reddy's Laboratories for the territory of Latin America, India, South Africa, and an option to expand the territory to include Australia and New Zealand and potential other countries.
    • View All

    August 2023 Commentary

    Generative AI End-User License Agreements: What Users Need to Know

    Additional Publications

    • January 14, 2021
      Structuring the Deal to Avoid Patent Exhaustion (Post Impression Products v. Lexmark), Transactions: The Tennessee Journal of Business Law, Fall 2020
    • May 7, 2020
      Defend Trade Secrets Act and The Seizure Provision: Useful or Superfluous?, Review of Intellectual Property Law - University of Illinois
    • March 1, 1997
      Performance of MHPM in Rician and Rayleigh fading mobile channels, IEEE Transactions on Communications, Volume: 45 Issue: 3

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.